Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 12, 2020

SELL
$66.76 - $93.49 $654,248 - $916,202
-9,800 Closed
0 $0
Q4 2019

Feb 11, 2020

BUY
$84.28 - $118.5 $825,944 - $1.16 Million
9,800 New
9,800 $892,000
Q3 2019

Nov 12, 2019

SELL
$84.4 - $106.53 $599,240 - $756,363
-7,100 Closed
0 $0
Q2 2019

Aug 12, 2019

BUY
$91.13 - $142.5 $647,023 - $1.01 Million
7,100 New
7,100 $744,000

Others Institutions Holding MDGL

About MADRIGAL PHARMACEUTICALS, INC.


  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.67B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Spark Investment Management LLC Portfolio

Follow Spark Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spark Investment Management LLC with notifications on news.